AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOGEN INC. Director's Dealing 2010

Jun 10, 2010

30291_dirs_2010-06-10_85f14aa6-c5b5-486a-b425-ba481a6ec011.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOGEN IDEC INC. (BIIB)
CIK: 0000875045
Period of Report: 2010-06-08

Reporting Person: ROSS BRUCE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-06-08	Common Stock	S	1000	$47.601	Disposed	10900	Direct
2010-06-08	Common Stock	S	1000	$47.6429	Disposed	9900	Direct

Footnotes

F1: Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.

F2: Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.

F3: This represents the weighted average price for shares sold at a range between $47.33 (low) and $48.07 (high).

F4: This represents the weighted average price for shares sold at a range between $47.37 (low) and $48.18 (high).